Innovative transaction strategies are more critical than ever in maximizing corporate value in the Life sciences. Nordic Life Science create value and reduce risk by fitting the right transaction strategy to the particular business situation at hand. We have extensive experience in Corporate Spin Outs and NewCo Incubations. This experience help our constituents to tailor-make a strategy according to their need.